Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Moderna, Inc. (MRNA)
Market Closed
17 Jul, 20:00
NASDAQ (NGS)
All
(16)
DE
(6)
AT
(1)
CH
(2)
PE
(1)
MX
(1)
IT
(2)
GB
(2)
US
(1)
NASDAQ (NGS)
Primary
LSE
XHAN
XSTU
XFRA
XDUS
XETRA
XMUN
XMIL
XMIL
BVL
XMEX
XWBO
CBOE
SIX
SIX
$
61.
82
-1.33
-2.1061%
$
27.09B
Market Cap
-
P/E Ratio
-
Div Yield
4.55M
Volume
-13.23
Eps
$
63.15
Previous Close
Investors:
DI
CE
WH
ABB
JD
+157
Analysts:
DG
Watching
Watch
Add Transaction
Day Range
61.06
63.28
Year Range
22.28
85.6
Want to track
MRNA
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Earnings
Splits
Statistics
News
Historical Data
Investors
Analysts
Moderna, Inc. (MRNA) Statistics
Valuation metrics
Market Cap
27.09B
Enterprise value
23.92B
Trailing P/E (ttm)
-7.59
Forward P/E
-11.15
PEG ratio
-3.78
Price/Sales (ttm)
11.02
Price/Book (mrq)
3.3
Enterprise Value/Revenue
10.75
Enterprise Value/EBITDA
-8.29
Overview
Shares outstanding
396.59M
Float
370.1M
Shares short
58.31M
% Held by insiders
0.07%
% Held by institutions
0.79%
Average volume (10 days)
5.53M
Average volume (90 days)
7.32M
Price summary
52-Week low
22.28
52-Week high
85.6
Beta
1.06
50-Day moving average
61.61
200-Day moving average
49.19
Dividends and splits
Forward annual dividend rate
-
Forward annual dividend yield
-
Trailing annual dividend rate
-
Trailing annual dividend yield
-
5-Year annual dividend yield
-
Payout ratio
-
Dividend Date
-
Ex-Dividend Date
-
Last split factor
1:10
Last split Date
3 Aug 2017
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Mar 2026
Profitability
Profit margin
-1.44%
Operating margin
-1.53%
Operational effectiveness
Return on assets
-0.28%
Return on equity
-0.37%
Income Statement
Revenue (ttm)
2.22B
Revenue per share (ttm)
5.63
Quarterly revenue growth (yoy)
2.6%
Gross profit (ttm)
-1.56B
EBITDA
-2.3B
Net income to common (ttm)
-3.19B
Diluted EPS (ttm)
-8.09
Quarterly earnings growth (yoy)
2.64%
Balance Sheet
Total cash (mrq)
5.21B
Total cash per share (mrq)
13.18
Total debt (mrq)
1.3B
Total Debt/Equity (mrq)
0.18
Current ratio (mrq)
2.41%
Book value per share (mrq)
18.75
Cash Flow
Cash flow statement
-1.47B
Levered free cash flow (LFCF)
-20M